How AI Is Detecting Lung Cancer From Low-Dose CT Scans

In this episode of Healthtech Talks, Lucas and Luna explore how artificial intelligence is being deployed to detect lung cancer earlier and more accurately from low-dose CT scans. They focus on a specific 2024 study from the Journal of Clinical Oncology that found AI screening reduced false positives by 40 percent compared to radiologist-only reads. The hosts break down the numbers: the 10,000-patient trial, the 24 percent improvement in detection of stage 1 nodules, and what this means for the 160,000 annual lung cancer deaths in the US. They also discuss the practical deployment challenges — integration into existing PACS systems, radiologist workflow acceptance, and training data bias. Plus, a brief look at how Google Health and a startup called Optellum are competing in this space. The episode is grounded in real data and avoids hype, giving listeners a clear picture of where AI stands in one of the most promising applications in cancer diagnostics. #AI #LungCancer #Healthtech #MedicalAI #CTScans #Radiology #EarlyDetection #CancerScreening #Optellum #GoogleHealth #BusinessAndTechnology #HealthtechTalks #FexingoBusiness #BusinessPodcast #LucasAndLuna #DiagnosticAI #Oncology #MachineLearning Keep every episode free: buymeacoffee.com/fexingo